Kalehua Capital Management LLC
Position in MLTX — MoonLake Immunotherapeutics
CIK 2106181
DALLAS, TX
Position in MLTX
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$3,421,540
+$145,859 QoQ
Shares Held
175,734
0.0% QoQ
Ownership
0.206%
of shares outstanding
% of Portfolio
2.41%
of 13F equity value
Holder Rank
#52
of 172 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MLTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Kalehua Capital Management LLC holds $130,283,970 across 24 Biotechnology names. MLTX ranks #15 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MANE |
Veradermics, Inc
|
145,695 | $17,911,743 | |
| 2 | XFOR |
X4 Pharmaceuticals, Inc
|
3,722,840 | $17,385,662 | |
| 3 | SRZN |
Surrozen, Inc./DE
|
385,178 | $9,995,369 | |
| 4 | ACRS |
Aclaris Therapeutics, Inc.
|
1,832,365 | $9,693,210 | |
| 5 | SION |
Sionna Therapeutics, Inc.
|
197,072 | $8,669,197 | |
| 6 | IKT |
Inhibikase Therapeutics, Inc.
|
3,821,890 | $7,758,436 | |
| 7 | PHVS |
Pharvaris N.V.
|
198,772 | $6,873,535 | |
| 8 | KPTI |
Karyopharm Therapeutics Inc.
|
685,644 | $6,698,741 |
All Filings in MLTX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,421,540 | 175,734 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $3,275,681 | 175,734 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,316,174 | 175,734 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||